Teladoc Health Inc
F:4LL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Teladoc Health Inc
F:4LL
|
US |
|
H
|
Heartland Group Holdings Ltd
F:73X
|
NZ |
|
Agrana Beteiligungs AG
F:AGB2
|
AT |
|
Spirax-Sarco Engineering PLC
LSE:SPX
|
UK |
|
A
|
Avance Gas Holding Ltd
F:A07
|
BM |
|
H
|
Humana Inc
SWB:HUM
|
US |
|
Note AB (publ)
STO:NOTE
|
SE |
|
Siloam International Hospitals Tbk PT
IDX:SILO
|
ID |
|
M
|
MorphoSys AG
DUS:MOR
|
DE |
|
B
|
Bed Bath & Beyond Inc
F:BBY
|
US |
|
R
|
Rex International Holding Ltd
F:RXI
|
SG |
|
A
|
Albany International Corp
F:AII
|
US |
Wall St Price Targets
4LL Price Targets Summary
Teladoc Health Inc
According to Wall Street analysts, the average 1-year price target for 4LL is 9.101 EUR with a low forecast of 6.255 EUR and a high forecast of 17.733 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4LL's stock price target?
Price Target
9.101
EUR
According to Wall Street analysts, the average 1-year price target for 4LL is 9.101 EUR with a low forecast of 6.255 EUR and a high forecast of 17.733 EUR.
What is the Revenue forecast for Teladoc Health Inc?
Projected CAGR
2%
Over the last 11 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 6 years is 2%.
What is the Gross Profit forecast for Teladoc Health Inc?
Projected CAGR
2%
Over the last 11 years, the compound annual growth rate for Gross Profit has been 43%. The projected CAGR for the next 6 years is 2%.
